BICC1 抗体 (AA 682-849)
Quick Overview for BICC1 抗体 (AA 682-849) (ABIN7165136)
抗原
See all BICC1 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 682-849
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human Protein bicaudal C homolog 1 protein (682-849AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Recommended dilution: IHC:1:200-1:500, IF:1:50-1:200,
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - BICC1 (Bicaudal C Homolog 1 (BICC1))
- 
                                            别名
- BICC1
- 
                                            背景
- 
                        Background: Putative RNA-binding protein. Acts as a negative regulator of Wnt signaling. May be involved in regulating gene expression during embryonic development. Aliases: Bic-C antibody, Bicaudal C homolog 1 (Drosophila) antibody, Bicc1 antibody, BICC1_HUMAN antibody, CYSRD antibody, Protein bicaudal C homolog 1 antibody 
- 
                                            UniProt
- Q9H694
 抗原
- 
                    
 
                                     
                                     
                                    